Medical News

RSS

Obama's closed-door signing of executive order on abortion funding raises objections

President Barack Obama signed an executive order Wednesday pledging that no federal funding will be used for abortion under the new health bill.

26 Mar 2010

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

Novavax, Inc. announced today positive results from the entire 1,000 subject Stage A of its two-stage pivotal study evaluating the safety and immunogenicity of Novavax's unadjuvanted 2009 A/H1N1 virus-like particle pandemic influenza vaccine.

26 Mar 2010

With reform, community health centers will see federal funds double

The Wall Street Journal reports that the health overhaul bill signed by President Barack Obama will increase spending "by $10 billion over five years for [some] clinics, known as community health centers. An additional $2.5 billion is included in a package of changes to that bill, which is expected to get final approval in Congress as soon as this week."

26 Mar 2010

Constitutional expert says new health reform law should stand up to legal court challenges

The newly signed health care reform law should stand up well to legal court challenges, says constitutional expert and political scientist Mark Graber of the University of Maryland.

26 Mar 2010

New gateway may be lifesaver for patients with AML: Study

Canadian researchers have discovered a previously hidden channel to attack leukemia and other cancer cells, according to a new study published in the Journal of Biological Chemistry. The findings from the Universit- de Montr-al, Maisonneuve-Rosemont Hospital and Universit- Laval may change the way doctors treat cancer patients.

26 Mar 2010

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

Santarus, Inc., a specialty biopharmaceutical company, today announced the completion of enrollment of 510 patients in a U.S. Phase III clinical study to evaluate budesonide MMX® administered over eight weeks for the induction of remission of mild or moderate active ulcerative colitis. This is the second Phase III clinical study being conducted in collaboration with Cosmo Technologies Ltd., a subsidiary of Cosmo Pharmaceuticals SpA, as part of the budesonide MMX Phase III clinical program for U.S. registration.

26 Mar 2010

New research may help advance treatment strategies for common liver disease

A research article published in the journal PloS Pathogens could lead to improvements in the production of vaccines for hepatitis A, the most widespread viral disease in the world.

26 Mar 2010

Cook Medical to feature its Goldstein SonoBiopsy Catheter at 2010 AIUM convention

With over 10 million women in the U.S. suffering from endometrial disorders like abnormal uterine bleeding or uterine fibroids, the 2010 American Institute of Ultrasound Medicine convention will feature specialized programs and product showcases highlighting imaging solutions available to better diagnose these conditions.

26 Mar 2010

White House scrambles to fix health bill language on covering sick kids

The White House is seeking to nail down a provision in the new law it says bars insurers from denying coverage to sick kids starting this year.

26 Mar 2010

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Novelos Therapeutics, Inc., a biopharmaceutical company focused on the development of therapeutics to treat cancer and hepatitis, today announced that it has enrolled the first patient in a U.S. Phase 2 trial evaluating NOV-205 as monotherapy in up to 40 chronic hepatitis C genotype 1 patients who previously failed treatment with pegylated interferon plus ribavirin.

26 Mar 2010

Leap Medical secures seed financing to develop innovative technology for detection of brain injuries

Leap Medical Inc., a privately held Medical Device company, announced today that it has successfully secured seed financing in the amount of $1.025 million (Canadian dollars) to develop its innovative technology for the rapid detection of brain injuries and infection.

26 Mar 2010

Civil society groups urge G8 to follow through with AIDS funding commitments

"Civil society organisations from around the world on Wednesday made a coordinated appeal to the Canadian government to help pressure the Group of Eight (G8) into fulfilling its aid commitments in the fight against AIDS,"

26 Mar 2010

Genetic variants in brain proteins may increase autism risk

Two genes have been associated with autistic spectrum disorders (ASD) in a new study of 661 families. Researchers writing in BioMed Central's newly launched journal Molecular Autism found that variations in the genes for two brain proteins, LRRN3 and LRRTM3, were significantly associated with susceptibility to ASD.

26 Mar 2010

Widely-used screening scale misidentifies borderline personality disorder as bipolar disorder

A study from Rhode Island Hospital has shown that a widely-used screening tool for bipolar disorder may incorrectly indicate borderline personality disorder rather than bipolar disorder.

26 Mar 2010

Top behavior problems of elderly parents

New study: Egg donors may be paid too much

"Women who donate eggs for use with in-vitro techniques aren't supposed to be compensated more than $10,000 .... according to guidelines from the American Society of Reproductive Medicine," The Wall Street Journal reports.

26 Mar 2010

Health IT roundup: Fears of hackers, efforts at fraud prevention

Some privacy advocates say the government is seeking to move too quickly to digitize health records, and may risk exposing sensitive information to identity thieves and hackers. These privacy advocates appear to favor slow progress is spreading electronic records because - they hope - consumer safeguards can keep up with that pace.

26 Mar 2010

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

IMDx announced today that its IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay has been granted Emergency Use Authorization from the U.S. Food and Drug Administration.

26 Mar 2010

Fluidigm, SABiosciences partner to create pathway-focused gene expression panels for BioMark system

Fluidigm Corporation and SABiosciences (a QIAGEN Company) today announced that they have teamed up to create over 100 pathway-focused gene expression panels validated for real-time PCR analysis on the Fluidigm BioMark™ System for Genetic Analysis. These kits are named the RT² Profiler™ PCR Arrays for the Fluidigm BioMark system.

26 Mar 2010

Standard HCV therapy less effective in urban minority patients: Study

A recent study confirms that the standard hepatitis C therapy, pegylated interferon and ribavirin, is significantly less effective in urban minority patients treated in an ordinary clinical practice setting compared with results produced during clinical trials.

26 Mar 2010

Medical News

Obama's closed-door signing of executive order on abortion funding raises objections

Positive results from Stage A pivotal study of 2009 A/H1N1 VLP pandemic influenza vaccine

With reform, community health centers will see federal funds double

Constitutional expert says new health reform law should stand up to legal court challenges

New gateway may be lifesaver for patients with AML: Study

Santarus enrolls 510 patients in Phase III clinical program for budesonide MMX

New research may help advance treatment strategies for common liver disease

Cook Medical to feature its Goldstein SonoBiopsy Catheter at 2010 AIUM convention

White House scrambles to fix health bill language on covering sick kids

Novelos Therapeutics commences enrollment in Phase 2 trial of NOV-205 for chronic hepatitis C

Leap Medical secures seed financing to develop innovative technology for detection of brain injuries

Civil society groups urge G8 to follow through with AIDS funding commitments

Genetic variants in brain proteins may increase autism risk

Widely-used screening scale misidentifies borderline personality disorder as bipolar disorder

Top behavior problems of elderly parents

New study: Egg donors may be paid too much

Health IT roundup: Fears of hackers, efforts at fraud prevention

IMDx 2009 Influenza A H1N1 Real-Time RT-PCR Assay granted EUA from FDA

Fluidigm, SABiosciences partner to create pathway-focused gene expression panels for BioMark system

Standard HCV therapy less effective in urban minority patients: Study

The Proteoform Puzzle: Unlocking the Next Frontier

Synthetic Biology and the Pursuit of Living Diagnostics

Modular, Scalable, Intelligent: How n6 Is Rethinking NGS Library Prep

Latest News